Ferguson Kenneth M. 4/A
4/A · Cyclacel Pharmaceuticals, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4/AAmended
Ferguson Kenneth M.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-14+47,467→ 47,467 totalExercise: $1.11From: 2023-06-14Exp: 2032-06-14→ Common Stock (47,467 underlying) - Award
Common Stock
2022-06-14+23,733→ 23,733 total
Footnotes (4)
- [F1]The Reporting Person received an award of 23,733 restricted stock units on June 14, 2022, which shall vest in three equal installments on June 14, 2023, June 14, 2024, and June 14, 2025.
- [F2]This Form 4 is being amended to correct a typographical error in the number of restricted stock units granted to the Reporting Person on June 14, 2022. 23,733 shares of restricted stock units were granted to the Reporting Person.
- [F3]The option will vest and become exercisable in equal monthly installments for thirty-six months beginning on the date of the grant, which is June 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
- [F4]These options were granted to Mr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.